REGISTER RECORD · clinicaltrials.gov

NCT01596062

Pharmacodynamics, Efficacy and Safety of Basiliximab 40 or 80 mg in Combination With Ciclosporine Microemulsion or Everolimus, in Adult Low Risk de Novo Renal Transplant Recipients (IDEALE Study)

AS THE REGISTER RECORDS IT

Status and dates

Status as listedCOMPLETED: completed
Register last updated2014-07-25
Retrieved by this site2026-10-03
Sourcehttps://clinicaltrials.gov/study/NCT01596062

What this record shows

This entry describes research activity. It is not a statement about market authorisation, and it is not regulatory, legal or medical advice: a trial being listed, completed or halted says nothing about whether a substance may be sold or used anywhere. Status wording is reproduced as the register writes it and is never mapped onto a simpler vocabulary.

All records · Method

WEEKLY

Register Watch, weekly

New trials, approvals and enforcement actions. One email a week.